{"id":15210,"date":"2020-02-13T06:31:09","date_gmt":"2020-02-13T11:31:09","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15210"},"modified":"2020-02-13T06:32:16","modified_gmt":"2020-02-13T11:32:16","slug":"no-quick-fix-missouri-finds-managing-pain-without-opioids-isnt-fast-or-easy","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15210","title":{"rendered":"No Quick Fix: Missouri Finds Managing Pain Without Opioids Isn\u2019t Fast Or Easy"},"content":{"rendered":"

(By Lauren Weber for Kaiser Health News)<\/p>\n

ST. LOUIS \u2014 Missouri began offering chiropractic care, acupuncture, physical therapy and cognitive-behavioral therapy for Medicaid patients in April, the latest state to try an alternative to opioids for those battling chronic pain.<\/p>\n

Yet only about 500 of the state\u2019s roughly 330,000<\/a> adult Medicaid users accessed the program through December, at a cost of $190,000, according to Josh Moore, the Missouri Medicaid pharmacy director. While the numbers may reflect an undercount because of lags in submitting claims, the jointly funded federal-state program known in the state as MO HealthNet is hitting just a fraction of possible patients so far.\u00a0 Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n

\"\"<\/a><\/p>\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Lauren Weber for Kaiser Health News) ST. LOUIS \u2014 Missouri began offering chiropractic care, acupuncture, physical therapy and cognitive-behavioral<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,21,20,16,15],"tags":[],"class_list":["post-15210","post","type-post","status-publish","format-standard","hentry","category-health-care-general","category-health-care-finance","category-health-care-redesign","category-medicaid","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15210"}],"version-history":[{"count":3,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15210\/revisions"}],"predecessor-version":[{"id":15213,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15210\/revisions\/15213"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}